139 related articles for article (PubMed ID: 22704519)
1. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients.
Weiss JM; Cufi P; Bismuth J; Eymard B; Fadel E; Berrih-Aknin S; Le Panse R
Immunobiology; 2013 Mar; 218(3):373-81. PubMed ID: 22704519
[TBL] [Abstract][Full Text] [Related]
2. Thymic remodeling associated with hyperplasia in myasthenia gravis.
Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
[TBL] [Abstract][Full Text] [Related]
3. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
[TBL] [Abstract][Full Text] [Related]
6. Thymus involvement in early-onset myasthenia gravis.
Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
9. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
10. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
[TBL] [Abstract][Full Text] [Related]
11. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.
Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S
Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049
[TBL] [Abstract][Full Text] [Related]
12. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
13. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
14. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
15. CXCL12/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2/Bax ratio.
Hernández-López C; Valencia J; Hidalgo L; Martínez VG; Zapata AG; Sacedón R; Varas A; Vicente A
Immunol Lett; 2008 Oct; 120(1-2):72-8. PubMed ID: 18692524
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
17. Thymic lymphocytes in myasthenia gravis.
Birnbaum G; Tsairis P
Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
[TBL] [Abstract][Full Text] [Related]
18. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
19. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
20. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S
Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]